News Search Results
Mar 08, 2025, 06:00 ET AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Mar 08, 2025, 06:00 ET AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Kyowa Kirin
Mar 07, 2025, 16:40 ET Spyre Therapeutics Announces Grants of Inducement Awards
March 7, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic combinations to target improved efficacy and convenience
More news about: Spyre Therapeutics, Inc.
Mar 07, 2025, 14:44 ET Amino Acid Assay Kit Market to Reach USD 421.9 million by 2030, Growing at an 6.6% CAGR - Credence Research
diagnostic programs, significantly driving market growth. 2. Expanding Applications in Biotechnology and Pharmaceuticals Amino acid assay kits have become essential tools in the biotechnology and pharmaceutical sectors, where they are used for drug discovery, protein characterization,
More news about: Credence Research Inc.
Mar 07, 2025, 14:01 ET BioLab Holdings, Inc. Announces Partnership with Real Collagen GmbH
Real Collagen GmbH, a German biotechnology company specializing in the manufacturing of fish collagen for treating medical conditions including chronic wounds
More news about: BioLab Sciences
Mar 07, 2025, 13:54 ET BioLab Holdings, Inc. Announces Partnership with Real Collagen GmbH
Real Collagen GmbH, a German biotechnology company specializing in the manufacturing of fish collagen for treating medical conditions including chronic wounds.
More news about: BioLab Sciences
Mar 07, 2025, 12:00 ET ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
offerings were insufficient to shield the Company from the adverse effects of a significant market downturn; (3) that the RFPs ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Mar 07, 2025, 08:58 ET Full Circles Therapeutics Secures U.S. Patent Allowance for Targeted Genome Modification Using Circular Single-Stranded DNA
innovation, Full Circles Therapeutics is actively seeking licensing and partnership opportunities for its cssDNA platform across the biotechnology and pharmaceutical industries. "We believe C4DNA™ GATALYST™ technology has immense potential across oncology,
More news about: Full Circles Therapeutics
Mar 07, 2025, 08:30 ET Lilly's EBGLYSS® (lebrikizumab-lbkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Mar 07, 2025, 08:01 ET Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India
More news about: Biocon Biologics Ltd.
Mar 07, 2025, 07:00 ET Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
signals have been seen in the pancreatic and anal cancer cohorts. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Mar 07, 2025, 05:53 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Mar 07, 2025, 05:46 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Mar 07, 2025, 03:28 ET Fermenta's Plant-based Vitamin D3 is 'Innovation of the Year'
certificated by global accreditations, and its world class R&D centre is located at Thane. Fermenta also possesses expertise in integrated biotechnology, such as enzymes for antibiotic synthesis, other niche APIs and environmental solutions. For more information about the Company and its businesses,
More news about: Fermenta Biotech Limited
Mar 07, 2025, 01:00 ET Nona Biosciences Integrates Cutting-Edge AI Technology to Enhance Its Fully Human Antibody Platform, Accelerating Antibody Discovery Across Key Therapeutic Areas
Mass., March 7, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced to unveil its innovative AI-assisted drug discovery
More news about: Nona Biosciences
Mar 06, 2025, 21:21 ET ICLR Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against ICON Public Limited Company (ICLR)
insufficient to shield the company from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 06, 2025, 18:27 ET GBM Health Holding Announces $1.5M Innovate BC Grant to Advance Breakthroughs in Precision Medicine and Sustainable Biotech
2025 /PRNewswire/ - GBM Health Holding, a global leader in integrated healthcare innovation, is proud to announce that its subsidiaries Gene Biotechnology Enterprises Ltd(Operating business as: "Gene Bio Medical") and Geno10X Bioscience Inc have been awarded a combined $1.5
More news about: Gene Bio Medical
Mar 06, 2025, 17:31 ET TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy | DelveInsight
GAIA-102 (GAIA BioMedicine), Rigosertib (Traws Pharma), HMBD-001 (Hummingbird Bioscience), PLB1004 (Avistone Biotechnology), ANS03 (Avistone Biotechnology), MYTX-011 (Mythic Therapeutics), A166 (Sichuan Kelun-Biotech Bio-pharmaceutical), Atamparib (BN-2397) (Ribon
More news about: DelveInsight Business Research, LLP
Mar 06, 2025, 16:30 ET Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements
Elevation Oncology cannot guarantee future events, results, actions, levels of activity, performance or achievements, and the timing and results of biotechnology development and potential regulatory approval are inherently uncertain. Forward-looking statements are subject to risks and uncertainties that may
More news about: Elevation Oncology
Mar 06, 2025, 14:56 ET Power Players Converge at the Hamm Institute for American Energy at OSU to Discuss Geothermal as a Solution to National Demand for Baseload Power
by increased manufacturing, artificial intelligence, and other expanding sectors. This is a critical issue as many emerging industries—such as biotechnology, quantum computing, semiconductors, and advanced manufacturing—will all require reliable energy," said Patterson. He also emphasized
More news about: Oklahoma State University
Mar 06, 2025, 11:31 ET Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50% CAGR - Credence Research
microplates is increasing as laboratories aim to improve throughput and reproducibility. Expansion of Biotechnology and Life Sciences Research With rapid advancements in biotechnology and molecular diagnostics, the need for reliable microplates in applications such as ELISA, PCR, and next-generation
More news about: Credence Research Inc.
Mar 06, 2025, 11:30 ET Molecular Spectroscopy Market Size Booms with CAGR 4.9% and Projected to Reach $5.6 Million by 2030 | Exclusive Report by The Insight Partners
Magnetic Resonance Spectroscopy, Raman Spectroscopy, Near-Infrared Spectroscopy, and Others), Application (Academic and Research Applications, Biotechnology Applications, Pharmaceutical Applications, and Others), and Geography (North America, Europe,
More news about: The Insight Partners
Mar 06, 2025, 08:30 ET Alexandria Real Estate Equities, Inc. Elects Claire Aldridge, PhD, to Board of Directors
"Dr. Aldridge's distinguished career in the life science industry spans more than 25 years across biotechnology, venture capital, entrepreneurship, technology commercialization and AI-accelerated therapeutic development," said Joel
More news about: Alexandria Real Estate Equities, Inc.
Mar 06, 2025, 08:00 ET Rice Biotech Launch Pad and RBL LLC launches Rice Venture Creation Fellowship
inaugural group of postdocs will begin the program in fall 2025. Ideal candidates will have a strong technical background in investing and developing biotechnology, proficiency in prototyping and data generation for risk assessment and the ability to engage and collaborate with scientific and clinical experts.
More news about: Rice University
Mar 06, 2025, 07:30 ET HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.